Product: Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
Reason for recall: Failed dissolution specifications: below specification results at stability 12-month
Recall initiated: 20230816
Status: Completed
Classification: Class III
Recall type: Voluntary: Firm initiated